powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1003958208
Milajurine Lindsay
P.A.
PRACTICE
MEDSTAR CLINICAL RESEARCH CENTER
See all providers at this practice →
Endocrinology
Washington,
DC
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
81.5
Quality
67.3
Cost
72.6
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.27%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 210023
Hospital
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
76
By payment type
Food and Beverage
$2K
Top paying entities
Food and Beverage
$2K
PRESCRIBING · PART D · 2024
Total Rx claims
1,218
Beneficiaries
—
Total drug cost
$749K
Distinct drugs
25
Brand share
61.8%
Top prescribed drugs
Semaglutide
168 claims
Empagliflozin
108 claims
Levothyroxine Sodium
95 claims
Tirzepatide
88 claims
Metformin Hcl
81 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
548
Unique beneficiaries
—
Total services
712
Distinct HCPCS
7
Medicare payment
$64K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 32 Endocrinology providers in DC — above median (cohort median 727).
